Intentar ORO - Gratis

'Pvt investment to pick up from second half of FY24'

Business Standard

|

December 07, 2023

India's growth prospects have brightened and, with capacity utilisation touching 70-90 per cent in three straight quarters, private investment is set to bounce back, says Confederation of Indian Industry (CII) President R DINESH. In an interview with Asit Ranjan Mishra & Shiva Rajora in New Delhi, Dinesh proposes a green transition fund to manage the climate challenge. Edited excerpts:

- Asit Ranjan Mishra & Shiva Rajora

'Pvt investment to pick up from second half of FY24'

What are India's medium-term growth prospects? How do you see headwinds and tailwinds playing out?

At the start of my term (as CII president), I had predicted that India will grow at a rate between 6.5 per cent and 6.7 per cent. Now, after the first half, I am confident to raise the rate to 6.8 per cent. For next year, the growth rate could be 7 per cent, though it will become clearer in the latter part of the year.

The headwinds mostly are macroeconomic and global issues.

Volatility is the larger challenge-things that unfold within a week or two. Those are the kind of big challenges we have. The good news is that the negative situation has bottomed out in Europe at least. The US is doing well, and we hope it will continue to do so.

As for tailwinds, some good work has been done on the infrastructure front. The ease of doing business has shifted to the cost of doing business, and the latter has two important pillarsinfrastructure investment and digitisation. Also, amid global volatility, India has become a sweet spot. Its large domestic market gives it the scope of becoming an export hub, so there is significant interest among foreign investors. In a way, that interest has continued after Covid.

If India's growth prospects, as you highlight, are bright, why has India Inc become risk-averse? With private investment not growing, we seem to be relying solely on the government's capital expenditure.

MÁS HISTORIAS DE Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Translate

Share

-
+

Change font size